- The price of the popular weight-loss jab Mounjaro is set to nearly triple on private prescription in the UK, rising from £122 to £330 for a month's supply of the highest doses.
- The 170 per cent price increase by owner Eli Lilly is part of a move to equalise costs across global markets, influenced by pressure from the Trump administration regarding international drug pricing.
- At least 500,000 people in the UK currently get Mounjaro or the rival weight-loss jab Wegovy through private prescriptions.
- The price rise will not affect the cost paid by the NHS, which began offering Mounjaro to eligible obese patients in June.
- New guidance from the National Institute for Health and Care Excellence (Nice) recommends that NHS patients completing treatment should be monitored for at least a year to mitigate weight regain.
IN FULL
